Fibromat (M) Berhad

KLSE:FIBRO Stock Report

Market Cap: RM 193.7m

Fibromat (M) Berhad Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Fibromat (M) Berhad.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth43.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • May 26

We Believe Fibromat (M) Berhad's (KLSE:FIBRO) Earnings Are A Poor Guide For Its Profitability

Despite posting strong earnings, Fibromat (M) Berhad's ( KLSE:FIBRO ) stock didn't move much over the last week. We...
New Narrative • Apr 10

Fibromat: More than just a niche player, with clearer earnings visibility from order book and project wins

Fibromat (M) Berhad may not be one of the most talked-about names on Bursa, but from a fundamental perspective, the company is starting to look more interesting than many investors may realise. The group is mainly involved in erosion control solutions , geotechnical-related installation works , and the manufacturing and sale of in-house erosion control products.
Analysis Article • Jan 15

Fibromat (M) Berhad's (KLSE:FIBRO) 31% Share Price Surge Not Quite Adding Up

Fibromat (M) Berhad ( KLSE:FIBRO ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Jan 14

Earnings Not Telling The Story For Fibromat (M) Berhad (KLSE:FIBRO) After Shares Rise 31%

Fibromat (M) Berhad ( KLSE:FIBRO ) shares have had a really impressive month, gaining 31% after a shaky period...
Analysis Article • Sep 04

Impressive Earnings May Not Tell The Whole Story For Fibromat (M) Berhad (KLSE:FIBRO)

Despite announcing strong earnings, Fibromat (M) Berhad's ( KLSE:FIBRO ) stock was sluggish. We did some digging and...
Analysis Article • Jul 04

The Market Lifts Fibromat (M) Berhad (KLSE:FIBRO) Shares 26% But It Can Do More

Fibromat (M) Berhad ( KLSE:FIBRO ) shareholders would be excited to see that the share price has had a great month...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Fibromat (M) Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KLSE:FIBRO - Analysts future estimates and past financials data (MYR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202612618-29-8N/A
12/31/202511316-27-8N/A
9/30/20259314-18-2N/A
6/30/20258712-24N/A
3/31/202573923N/A
12/31/2024751034N/A
9/30/2024759N/AN/AN/A
6/30/2024758910N/A
3/31/20247281111N/A
12/31/20236881213N/A
9/30/2023597N/AN/AN/A
6/30/202349512N/A
3/31/202349501N/A
12/31/2022484-10N/A
9/30/2022474N/AN/AN/A
6/30/2022464-10N/A
3/31/202246512N/A
12/31/202146635N/A
9/30/2021508N/AN/AN/A
6/30/2021531112N/A
3/31/202149912N/A
12/31/202044812N/A
9/30/202037355N/A
6/30/202030-389N/A
3/31/202036-366N/A
12/31/201942-3N/A3N/A
12/31/2018613N/A4N/A
12/31/2017486N/A2N/A
12/31/2016445N/A5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if FIBRO's forecast earnings growth is above the savings rate (3.8%).

Earnings vs Market: Insufficient data to determine if FIBRO's earnings are forecast to grow faster than the MY market

High Growth Earnings: Insufficient data to determine if FIBRO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if FIBRO's revenue is forecast to grow faster than the MY market.

High Growth Revenue: Insufficient data to determine if FIBRO's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if FIBRO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/18 16:02
End of Day Share Price 2026/08/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fibromat (M) Berhad is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ley Yee LowMalacca Securities Sdn Bhd